首页> 外文会议>IEEE Systems and Information Engineering Design Symposium >Identifying risk of progression for patients with Chronic Kidney Disease using clustering models
【24h】

Identifying risk of progression for patients with Chronic Kidney Disease using clustering models

机译:使用聚类模型确定慢性肾病患者进展的风险

获取原文

摘要

Chronic Kidney Disease ("CKD") and its comorbidities, diabetes, hypertension and cardiovascular disease ("CVD"), are frequently measured by routine procedures and lab tests, creating a large amount of historical data about this patient population. In this paper, we conducted a retrospective study based on Electronic Health Records ("EHR") data, in order to identify patterns in the development of CKD. In particular, we used a clustering approach to quantifiably identify diabetic patients who are at risk of progressing to advanced stages of CKD. Using values from routine measurements and lab tests such as systolic blood pressure, diastolic blood pressure, body mass index ("BMI"), Hemoglobin A1c ("HbAlc"), triglycerides and high density lipid cholesterol ("HDL cholesterol"), patients were classified into four clusters with a distinct separation between the cluster with the best value for each lab test and a cluster with the worst value for each lab test. We used lab values from each subsequent visit to calculate a progression score using the distance to the best and worst clusters, which indicated whether a patient's health was improving or deteriorating. We believe that this approach holds promise for future tools, as it is able to provide an ordered list of patients who are at greater risk of deterioration and should benefit from intervention by healthcare providers. The conclusions made in this paper are aimed at enabling timely monitoring and earlier intervention for patients that are associated with higher possibility of CKD progression.
机译:慢性肾病(“CKD”)及其糖尿病,糖尿病,高血压和心血管疾病(“CVD”)经常通过常规程序和实验室测试来衡量,从而产生关于该患者人口的大量历史数据。在本文中,我们基于电子健康记录(“EHR”)数据进行了回顾性研究,以确定CKD发展中的模式。特别是,我们使用聚类方法来衡量有可能进入CKD的高级阶段的糖尿病患者。使用来自常规测量的值和实验室测试,例如收缩压,舒张压,体重指数(“BMI”),血红蛋白A1C(“HBALC”),甘油三酯和高密度脂质胆固醇(“HDL胆固醇”),患者是分为四个集群,在集群之间具有不同的分离,每个实验室测试的最佳值和每个实验室测试的最差值的群集。我们使用每个后续访问的实验室值来计算使用与最佳和最差簇的距离的进展分数,这表明患者的健康是否正在改善或恶化。我们认为,这种方法持有未来工具的承诺,因为它能够提供更大风险恶化风险的患者的有序列表,并应从医疗保健提供者的干预中受益。本文完成的结论旨在使及时监测及早期干预与CKD进展较高有关的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号